About Tenvir-EM Emtricitabine and Tenofovir Disoproxil Fumarate
TENMACEM
Each tablet contains
Tenofovir Disoproxil Fumarate 300 mg
Emtricitabine 200mg
CONTRAINDICATIONS
Do not use TENMACEM for preexposure prophylaxis in individuals with unknown or positive HIV1 status TENMACEM should be used in HIVinfected patients only in combination with other antiretroviral agents
SIDE EFFECTS
In HIV1 infected patients the most common adverse reactions incidence greater than or equal to 10 are diarrhea nausea fatigue headache dizziness depression insomnia abnormal dreams and rash In HIV1 uninfected individuals in PrEP trials adverse reactions that were reported by more than 2 of TENMACEM subjects and more frequently than by placebo subjects were headache abdominal pain and weight decreased
PACKING
HDPE Bottle packs of 30 tablets and packed in a unit carton along with package insert
SHELF LIFE AND STORAGE
24 months from the date of manufacturing below 30C
Key Ingredients and FormTenvir-EM contains two active pharmaceutical ingredients: Emtricitabine (200mg) and Tenofovir Disoproxil Fumarate (300mg). These antiviral agents are combined into a single tablet, streamlining the daily treatment process for individuals living with HIV. The tablet's pharmaceutical grade ensures consistent quality suitable for diverse applications, including distribution, export, and direct patient use.
Dosage Guidelines and Usage RecommendationsThe recommended dosage of Tenvir-EM is as prescribed by a physician, tailored to each patient's needs. Patients should take one tablet daily, ideally at the same time each day, to maintain stable medication levels in the body. It is important not to alter the prescribed dose or skip doses without consulting your healthcare provider.
Proper Storage InstructionsTo preserve the efficacy of Tenvir-EM, store the medication at room temperature (approximately 25C). Keep the tablets in a cool, dry place, away from direct sunlight and moisture. Do not store it in bathrooms or near heat sources, and ensure the container is tightly closed and out of reach of children.
FAQ's of Tenvir-EM Emtricitabine and Tenofovir Disoproxil Fumarate:
Q: How should Tenvir-EM be taken for optimal results?
A: Tenvir-EM should be taken exactly as directed by your physician, usually once daily with or without food. Taking the tablet at the same time each day helps maintain an even level of medicine in your system, increasing its effectiveness.
Q: What is the primary benefit of using Tenvir-EM for HIV-positive patients?
A: Tenvir-EM effectively helps control the replication of the HIV virus in the body, reducing the viral load and supporting immune function. Consistent use as prescribed can improve overall health outcomes and reduce the risk of HIV-related complications.
Q: When should you consult your physician regarding Tenvir-EM treatment?
A: Consult your physician if you miss a dose, experience side effects, or have concerns about drug interactions with other medicines. Also, seek medical advice before making any changes to your dosage or administration routine.
Q: Where should Tenvir-EM tablets be stored to maintain their potency?
A: Store Tenvir-EM at room temperature (25C) in a cool and dry place, away from direct sunlight and moisture. Avoid storing the tablets in humid environments such as bathrooms to prevent degradation.
Q: What is the process for distributing or exporting Tenvir-EM tablets from India?
A: Tenvir-EM, manufactured in India, is distributed, exported, and supplied by authorized pharmaceutical companies, meeting international standards. Each batch is rigorously tested for quality to ensure safe and effective delivery to healthcare facilities and patients globally.
Q: Is it necessary to take Tenvir-EM with food?
A: Tenvir-EM can be taken with or without food. However, taking it with a meal may help reduce the risk of stomach upset. Always follow your doctor's specific instructions regarding administration.